Correction to: SGLT2 inhibitors and lower limb complications: an updated meta-analysis (Cardiovascular Diabetology, (2021), 20, 1, (91), 10.1186/s12933-021-01276-9)

Chu Lin, Xingyun Zhu, Xiaoling Cai*, Wenjia Yang, Fang Lv, Lin Nie, Linong Ji*

*此作品的通讯作者

科研成果: 期刊稿件评论/辩论

2 引用 (Scopus)
Plum Print visual indicator of research metrics
  • Citations
    • Citation Indexes: 2
  • Captures
    • Readers: 23
see details

摘要

An amendment to this paper has been published and can be accessed via the original article.

源语言英语
文章编号119
期刊Cardiovascular Diabetology
20
1
DOI
出版状态已出版 - 12月 2021
已对外发布

指纹

探究 'Correction to: SGLT2 inhibitors and lower limb complications: an updated meta-analysis (Cardiovascular Diabetology, (2021), 20, 1, (91), 10.1186/s12933-021-01276-9)' 的科研主题。它们共同构成独一无二的指纹。

引用此

Lin, C., Zhu, X., Cai, X., Yang, W., Lv, F., Nie, L., & Ji, L. (2021). Correction to: SGLT2 inhibitors and lower limb complications: an updated meta-analysis (Cardiovascular Diabetology, (2021), 20, 1, (91), 10.1186/s12933-021-01276-9). Cardiovascular Diabetology, 20(1), 文章 119. https://doi.org/10.1186/s12933-021-01306-6